ProQR Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.

About PRQR

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. 

CEO
Daniel Anton de Boer
CEODaniel Anton de Boer
Employees
157
Employees157
Headquarters
Leiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded
2012
Founded2012
Employees
157
Employees157

PRQR Key Statistics

Market cap
192.34M
Market cap192.34M
Price-Earnings ratio
-6.30
Price-Earnings ratio-6.30
Dividend yield
Dividend yield
Average volume
204.07K
Average volume204.07K
High today
High today
Low today
Low today
Open price
$2.40
Open price$2.40
Volume
0.00
Volume0.00
52 Week high
$3.65
52 Week high$3.65
52 Week low
$1.11
52 Week low$1.11

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.